215 related articles for article (PubMed ID: 36545230)
1. Aiming at harmony. Comparing and contrasting International HFrEF Guidelines.
Tomasoni D; Adamo M; Bozkurt B; Heidenreich P; McDonagh T; Rosano GMC; Virani SA; Zieroth S; Metra M
Eur Heart J Suppl; 2022 Dec; 24(Suppl L):L20-L28. PubMed ID: 36545230
[TBL] [Abstract][Full Text] [Related]
2. ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.
Behnoush AH; Khalaji A; Naderi N; Ashraf H; von Haehling S
ESC Heart Fail; 2023 Jun; 10(3):1531-1544. PubMed ID: 36460629
[TBL] [Abstract][Full Text] [Related]
3. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines.
Bozkurt B
Curr Cardiol Rep; 2018 Apr; 20(6):39. PubMed ID: 29667019
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines.
Bayés-Genís A; Aimo A; Metra M; Anker S; Seferovic P; Rapezzi C; Castiglione V; Núñez J; Emdin M; Rosano G; Coats AJS
Eur J Heart Fail; 2022 Jun; 24(6):916-926. PubMed ID: 35579428
[TBL] [Abstract][Full Text] [Related]
5. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Heidenreich PA; Bozkurt B; Aguilar D; Allen LA; Byun JJ; Colvin MM; Deswal A; Drazner MH; Dunlay SM; Evers LR; Fang JC; Fedson SE; Fonarow GC; Hayek SS; Hernandez AF; Khazanie P; Kittleson MM; Lee CS; Link MS; Milano CA; Nnacheta LC; Sandhu AT; Stevenson LW; Vardeny O; Vest AR; Yancy CW
J Am Coll Cardiol; 2022 May; 79(17):1757-1780. PubMed ID: 35379504
[TBL] [Abstract][Full Text] [Related]
6. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Heidenreich PA; Bozkurt B; Aguilar D; Allen LA; Byun JJ; Colvin MM; Deswal A; Drazner MH; Dunlay SM; Evers LR; Fang JC; Fedson SE; Fonarow GC; Hayek SS; Hernandez AF; Khazanie P; Kittleson MM; Lee CS; Link MS; Milano CA; Nnacheta LC; Sandhu AT; Stevenson LW; Vardeny O; Vest AR; Yancy CW
J Am Coll Cardiol; 2022 May; 79(17):e263-e421. PubMed ID: 35379503
[TBL] [Abstract][Full Text] [Related]
7. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Heidenreich PA; Bozkurt B; Aguilar D; Allen LA; Byun JJ; Colvin MM; Deswal A; Drazner MH; Dunlay SM; Evers LR; Fang JC; Fedson SE; Fonarow GC; Hayek SS; Hernandez AF; Khazanie P; Kittleson MM; Lee CS; Link MS; Milano CA; Nnacheta LC; Sandhu AT; Stevenson LW; Vardeny O; Vest AR; Yancy CW
Circulation; 2022 May; 145(18):e876-e894. PubMed ID: 35363500
[TBL] [Abstract][Full Text] [Related]
8. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Heidenreich PA; Bozkurt B; Aguilar D; Allen LA; Byun JJ; Colvin MM; Deswal A; Drazner MH; Dunlay SM; Evers LR; Fang JC; Fedson SE; Fonarow GC; Hayek SS; Hernandez AF; Khazanie P; Kittleson MM; Lee CS; Link MS; Milano CA; Nnacheta LC; Sandhu AT; Stevenson LW; Vardeny O; Vest AR; Yancy CW
Circulation; 2022 May; 145(18):e895-e1032. PubMed ID: 35363499
[TBL] [Abstract][Full Text] [Related]
9. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
Ahmed A
J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society.
Kasprzak JD; Gorczyca-Głowacka I; Sobczak-Kaleta M; Barylski M; Drożdż J; Filipiak KJ; Kapłon-Cieślicka A; Lelonek M; Mamcarz A; Ochijewicz D; Ryś-Czaporowska A; Starzyk K; Szymański FM; Wełnicki M; Wożakowska-Kapłon B
Kardiol Pol; 2023; 81(5):537-556. PubMed ID: 37179465
[TBL] [Abstract][Full Text] [Related]
11. Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium.
Kourek C; Briasoulis A; Papamichail A; Xanthopoulos A; Tsougos E; Farmakis D; Paraskevaidis I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542088
[TBL] [Abstract][Full Text] [Related]
12. Varying effects of recommended treatments for heart failure with reduced ejection fraction: meta-analysis of randomized controlled trials in the ESC and ACCF/AHA guidelines.
Thomsen MM; Lewinter C; Køber L
ESC Heart Fail; 2016 Dec; 3(4):235-244. PubMed ID: 27867524
[TBL] [Abstract][Full Text] [Related]
13. Management of heart failure: similarities and discrepancies between the European Society of Cardiology and the American Heart Association guidelines.
Parlati ALM; Basile C; Perrone-Filardi P
Eur Heart J Suppl; 2023 May; 25(Suppl C):C271-C275. PubMed ID: 37125281
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy implications of revised chronic heart failure guidelines.
Crouch MA
Consult Pharm; 2006 Jul; 21(7):576-82. PubMed ID: 16934010
[TBL] [Abstract][Full Text] [Related]
15. Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines.
MacDonald BJ; Virani SA; Zieroth S; Turgeon R
CJC Open; 2023 Aug; 5(8):629-640. PubMed ID: 37720183
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
Mullens W; Martens P; Testani JM; Tang WHW; Skouri H; Verbrugge FH; Fudim M; Iacoviello M; Franke J; Flammer AJ; Palazzuoli A; Barragan PM; Thum T; Marcos MC; Miró Ò; Rossignol P; Metra M; Lassus J; Orso F; Jankowska EA; Chioncel O; Milicic D; Hill L; Seferovic P; Rosano G; Coats A; Damman K
Eur J Heart Fail; 2022 Apr; 24(4):603-619. PubMed ID: 35239201
[TBL] [Abstract][Full Text] [Related]
17. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Yancy CW; Jessup M; Bozkurt B; Butler J; Casey DE; Colvin MM; Drazner MH; Filippatos G; Fonarow GC; Givertz MM; Hollenberg SM; Lindenfeld J; Masoudi FA; McBride PE; Peterson PN; Stevenson LW; Westlake C
J Am Coll Cardiol; 2016 Sep; 68(13):1476-1488. PubMed ID: 27216111
[No Abstract] [Full Text] [Related]
18. Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction.
Al-Mohammad A
ESC Heart Fail; 2019 Aug; 6(4):878-883. PubMed ID: 31119890
[TBL] [Abstract][Full Text] [Related]
19. A year in heart failure: an update of recent findings.
Stretti L; Zippo D; Coats AJS; Anker MS; von Haehling S; Metra M; Tomasoni D
ESC Heart Fail; 2021 Dec; 8(6):4370-4393. PubMed ID: 34918477
[TBL] [Abstract][Full Text] [Related]
20. Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines.
Badger S; McVeigh J; Indraratna P
Cardiol Ther; 2023 Dec; 12(4):571-588. PubMed ID: 37653361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
